阴神经阻塞与乙氨基和咖啡因相比,用于怀孕期间治疗头痛:一项随机对照试验
Elisa T Bushman1, Christina T Blanchard, Gabriella D Cozzi
1Center for Women's Reproductive Health, the Department of Obstetrics and Gynecology, the Department of Biostatistics, and the Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama; the Department of Women's Health, University of Texas at Austin, Dell Medical School, Austin, Texas; and the Department of Neuro-ophthalmology, University of Utah, Salt Lake City, Utah.
Obstetrics and gynecology
|September 28, 2023
概括
尾神经阻断为怀孕期间急性头痛提供了快速有效的治疗方法,比标准护理更快地减轻疼痛. 这种头痛缓解方法是孕妇寻求迅速症状管理的可行选择.
科学领域:
- 产科和妇科 产科和妇科
- 神经学 神经学
- 疼痛管理 疼痛管理
背景情况:
- 急性头痛是怀孕期间常见的抱怨.
- 标准的治疗方法,如乙氨基与咖啡因,可能有局限性.
- 评估替代性,有效的干预措施对于孕产妇健康至关重要.
研究的目的:
- 为了比较尾神经阻断与孕妇急性头痛标准护理的疗效.
- 评估疼痛减轻和患者对两种治疗方案的满意度.
主要方法:
- 一个单一中心的随机对照试验,涉及62名怀孕患者,患有中度至严重的头痛.
- 参与者被随机分配,接受尾神经阻塞或标准护理 (乙氨基与咖啡因).
- 交叉和二线治疗用于症状恶化;主要结局是头痛在2小时内改善.
主要成果:
- 在初级结局 (头痛在2小时内改善) 中,两组之间没有显著差异 (64.5%与51.6%,P=.30).
- 尾神经阻塞组在1小时内显著降低疼痛评分 (P = .014) 和更快的疼痛缓解.
- 在标准护理组中,交叉到尾神经阻塞导致了显著的疼痛减轻.
结论:
- 尾神经阻塞是孕期急性头痛的快速有效治疗方法.
- 与标准护理相比,它提供更快的疼痛缓解,尽管主要结果没有显著差异.
- 进一步的研究可能会探索其在管理与怀孕有关的头痛方面的作用.
相关概念视频
01:29Local Anesthetics: Clinical Application as Epidural Anesthesia
452
Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
452
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
184
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
184